| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | United States | 3 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Israel | 2 | |
| #6 | United Kingdom | 1 | |
| #7 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Therapeutic chemical compounds | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Savage Philip Michael | 7 |
| #2 | Savage Philip | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB0426903D0 | Complexes and methods | |
| US7521197B2 | Method for producing cytotoxic T-cells | |
| AU2002301994A1 | Method for producing cytotoxic T-cells | |
| US7264965B2 | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means | |
| IL139950D0 | Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |